HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph D Spahn Selected Research

Asthma (Bronchial Asthma)

11/2023Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
1/2023Effect of Biologic Therapies on Airway Hyperresponsiveness and Allergic Response: A Systematic Literature Review.
10/2020Fractional exhaled nitric oxide response to oral corticosteroids in children with mild-to-moderate asthma: Influence of race.
11/2019Proportion of Severe Asthma Patients Eligible for Mepolizumab Therapy by Age and Age of Onset of Asthma.
11/2015The Effect of Viral Infection on Exhaled Nitric Oxide in Children with Acute Asthma Exacerbations.
9/2014The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children.
8/2014Eczema and race as combined determinants for differential response to step-up asthma therapy.
3/2014The changing face of severe childhood asthma: a comparison of two cohorts of children evaluated at National Jewish Health over the past 20 years.
5/2013Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice.
8/2012Asthma biomarkers in sputum.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph D Spahn Research Topics

Disease

32Asthma (Bronchial Asthma)
11/2023 - 01/2002
8Inflammation (Inflammations)
11/2019 - 08/2002
2Respiratory Hypersensitivity
01/2023 - 02/2010
2Eosinophilia
11/2019 - 11/2007
2Airway Obstruction (Choking)
04/2006 - 08/2002
1Hypersensitivity (Allergy)
11/2023
1Chronic Cough
01/2022
1Nasal Polyps (Nasal Polyp)
11/2019
1Virus Diseases (Viral Diseases)
11/2015
1Eczema
08/2014
1Bronchial Spasm
09/2004

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
10/2020 - 08/2004
8Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2020 - 05/2003
7GlucocorticoidsIBA
03/2014 - 08/2002
5Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020 - 08/2002
5SteroidsIBA
11/2019 - 01/2002
5Fluticasone (Cutivate)FDA LinkGeneric
03/2010 - 06/2004
4Budesonide (Pulmicort)FDA LinkGeneric
02/2010 - 05/2003
4Nedocromil (Alocril)FDA Link
02/2010 - 05/2003
4montelukast (Singulair)FDA Link
01/2007 - 02/2005
3Methacholine Chloride (Methacholine)FDA Link
01/2022 - 01/2007
3Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
03/2014 - 06/2007
3Bronchodilator Agents (Bronchodilators)IBA
01/2007 - 09/2004
3Albuterol (Salbutamol)FDA LinkGeneric
04/2006 - 05/2003
2tezepelumabIBA
11/2023 - 01/2023
2AllergensIBA
01/2023 - 02/2010
2Eosinophil Cationic ProteinIBA
09/2004 - 05/2003
1Coenzyme A (CoA)IBA
11/2019
1Indicators and Reagents (Reagents)IBA
11/2019
1mepolizumabIBA
11/2019
1ChitinasesIBA
09/2014
1Immunoglobulin E (IgE)IBA
09/2014
1Proteins (Proteins, Gene)FDA Link
09/2014
1Salmeterol Xinafoate (Serevent)FDA Link
01/2007
1Prednisone (Sone)FDA LinkGeneric
09/2004
1LeukotrienesIBA
06/2003
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
08/2002
1InterleukinsIBA
08/2002
1Protein Isoforms (Isoforms)IBA
08/2002
1CytokinesIBA
08/2002
1glucocorticoid receptor betaIBA
08/2002
1Interleukin-4 (Interleukin 4)IBA
08/2002

Therapy/Procedure

18Therapeutics
10/2020 - 01/2002
1Biological Therapy
01/2023
1Ambulatory Care (Outpatient Care)
11/2015
1Drug Therapy (Chemotherapy)
03/2014
1Metered Dose Inhalers (Metered Dose Inhaler)
06/2004